Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | SI | P14410 | 2/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2915211 | 1.00 | MGAM (0.44) | MGAMGAASIMGAM2HTT | |
| SCHEMBL27865778 | 1.00 | MGAM (0.44) | MGAMGAASIMGAM2HTT | |
| SCHEMBL27882158 | 0.80 | MGAM (0.46) | MGAMGAASIMGAM2HTT | |
| SCHEMBL27882156 | 0.80 | MGAM (0.46) | MGAMGAASIMGAM2HTT | |
| SCHEMBL27713834 | 0.79 | MGAM (0.40) | MGAMGAASIMGAM2 | |
| SCHEMBL27641880 | 0.78 | — | — | |
| SCHEMBL8744844 | 0.78 | — | — | |
| SCHEMBL27997655 | 0.78 | — | — | |
| SCHEMBL16667687 | 0.76 | MGAM (0.50) | MGAMGAASIMGAM2HTT | |
| SCHEMBL28125722 | 0.76 | MGAM (0.50) | MGAMGAASIMGAM2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111072515-B | Method for continuously synthesizing thiaminoximic acid intermediate | 普洛药业股份有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-111072515-A | Method for continuously synthesizing thiaminoximic acid intermediate | 山东普洛得邦医药有限公司 | 2020-04-28 | — | — | CN | claimed |
| CN-111072515-B | Method for continuously synthesizing thiaminoximic acid intermediate | 普洛药业股份有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-111072515-B | Method for continuously synthesizing thiaminoximic acid intermediate | 普洛药业股份有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-111072515-A | Method for continuously synthesizing thiaminoximic acid intermediate | 山东普洛得邦医药有限公司 | 2020-04-28 | — | — | CN | disclosed |
| CN-111072515-A | Method for continuously synthesizing thiaminoximic acid intermediate | 山东普洛得邦医药有限公司 | 2020-04-28 | — | — | CN | disclosed |
| CN-110218194-A | A kind of the 3- methyl-quinoxaline -2- carboxylic acid and its synthetic method of stable isotope labeling | 上海安谱实验科技股份有限公司 | 2019-09-10 | — | — | CN | disclosed |
| CN-109689631-A | Method for preparing 3- (trifluoromethyl) pyrazine-2-formic ether | 隆萨有限公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-102603746-B | Carbapenem derivative | KBP BIOSCIENCES CO LTD | 2015-07-15 | — | — | CN | disclosed |
| EP-2223969-B1 | RESIN COMPOSITION, TRANSPARENT MEMBER OBTAINED FROM THE RESIN COMPOSITION, AND USE OF THE SAME | MITSUI CHEMICALS INC (JP) | 2015-02-25 | — | — | EP | disclosed |
| US-8648130-B2 | Resin composition, transparent member obtained from the resin composition, and use of the same | MITSUI CHEMICALS, INC. (JP) | 2014-02-11 | — | — | US | disclosed |
| CN-102603746-A | Carbapenem derivative | KBP BIOSCIENCES CO LTD | 2012-07-25 | — | — | CN | disclosed |
| US-20100256271-A1 | RESIN COMPOSITION, TRANSPARENT MEMBER OBTAINED FROM THE RESIN COMPOSITION, AND USE OF THE SAME | MITSUI CHEMICALS, INC. (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2223969-A1 | RESIN COMPOSITION, TRANSPARENT MEMBER OBTAINED FROM THE RESIN COMPOSITION, AND USE OF THE SAME | Mitsui Chemicals, Inc. (JP) | 2010-09-01 | — | — | EP | disclosed |
| CN-1960984-B | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists | HOFFMANN LA ROCHE | 2010-05-12 | — | — | CN | disclosed |
| CN-1960984-A | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists | HOFFMANN LA ROCHE (CH) | 2007-05-09 | — | — | CN | disclosed |